Can We Prevent End-Stage Renal Disease due to Hypertension or to Diabetes Mellitus?

JAMA: The Journal of the American Medical Association

Volumn 268, Issue 21, 1992, Pages 3119-3120

  Luke, Robert G ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; DIABETES MELLITUS; DISEASE CONTROL; EDITORIAL; GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; NEGRO; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR;

ADULT; AGED; DIABETES MELLITUS; HUMAN; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MIDDLE AGE; NEGROID RACE; NEPHROSCLEROSIS;

EID: 0026490276     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1992.03490210101043     Document Type: Article

References (12)

1. Excerpts from United States Renal Data System 1991 Annual Data Report. Am J Kidney Dis. 1991;18(suppl 5):1-93.
2. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306:1276-1279.
3. Qualheim RD, Rostand SG, Kirk KA, Rutsky EA, Luke RG. Changing patterns of end-stage renal disease due to hypertension. Am J Kidney Dis. 1991;18:335-343.
4. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks: a population-based study of potential explanatory factors. JAMA. 1992;268:3079-3084.
5. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD, for the MRFIT Research Group. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. JAMA. 1992;268:3085-3091.
6. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. N Engl J Med. 1989;320:1161-1164.
7. Reaven GM, Hoffman BB. Hypertension as a disease of carbohydrate and lipoprotein metabolism. Am J Med. 1989;87(suppl 6):2S-6S.
8. Whittle JC, Whelton PK, Seidler AJ, Klag MJ. Does racial variation in risk factors explain black-white-differences in the incidence of hypertensive end stage renal disease? Arch Intern Med. 1991;151:1359-1364.
9. Luke RG. Can renal failure due to hypertension be prevented? Hypertension. 1991;18(suppl 3):1139-1141.
10. Littenberg B, Garber AM, Sox HC. Screening for hypertension. Ann Intern Med. 1990;112:192-202.
11. The National High Blood Pressure Program Working Group. Reports on hypertension and chronic renal failure. Arch Intern Med. 1991;151:1280-1287.
12. Saunders E, Weir MR, Kong BW, et al. A comparison of the efficacy and safety of a B-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med. 1990;150:1707-1713.